Clinical Trial

Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM

Study acronym: DIACHIRO
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study evaluates the efficacy of D-Chiro-Inositol (DCI) as an add-on therapy to metformin in improving insulin resistance, measured by the HOMA index, in people with overweight or obesity and type 2 diabetes mellitus (T2DM). Secondary outcomes include glycemic variability, indirect calorimetry, respiratory quotient, and other metabolic parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-28.
Trial Details
NCT Number NCT06860841
Lead Sponsor Campus Bio-Medico University
Conditions Type 2 Diabetes, Overweight and Obese Adults
Enrollment 16 participants
Start Date 2025-01-10
Primary Completion 2025-02-10 (estimated)
Study Completion 2025-04-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-11